Summary
- Current Price
- As of today, WAT price is $377.31, down -0.79% on
- Current Price All-Time High
- WAT price is currently -11.89% below its historical high of $428.22 set on
- Market Cap
- WAT current market cap is $37B, up +114.42% over the past 365 days
- PE Ratio
- WAT current PE ratio is 48.03
- Revenue
- WAT current annual revenue is $3.17B, up +6.99% year-over-year
- Next Earnings
- The next earnings release for WAT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Waters Corporation |
| Ticker | NYSE: WAT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | waters.com |
| Employees | 7,600 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $377.31 | |
| Price, 1D Change | -0.79% | |
| Market Cap | $37B | |
| - | ||
| PE Ratio | 48.03 | |
| Beta | 0.82 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +6.99% | |
| EPS | $10.76 | |
| EPS, 1Y Change | +0.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $10.76 | |
| EPS Estimate | N/A | $14.51 |
| EPS Est. Change | N/A | +34.85% |
| Revenue | $3.17B | |
| Revenue Estimate | N/A | $6.44B |
| Revenue Est. Change | N/A | +103.51% |
| Current Price | $377.31 | |
| Price Target | - | $420.00 |
| Price Tgt. Change | - | +11.31% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.80 | $10.71 | -9.25% | |
| $13.11 | $10.76 | -17.92% | |
| $14.51 | N/A | +34.85% | |
| $16.49 | N/A | +53.24% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.94B | $2.96B | +0.61% | |
| $3.16B | $3.17B | +0.10% | |
| $6.44B | N/A | +103.51% | |
| $7.11B | N/A | +124.64% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +29.97% | |
| Price, 3Y | +29.48% | |
| Market Cap, 1Y | +114.42% | |
| Market Cap, 3Y | +115.30% | |
| Revenue, 1Y | +6.99% | |
| Revenue, 3Y | +6.51% | |
| EPS, 1Y | +0.49% | |
| EPS, 3Y | -8.25% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $377.31 | |
| SMA 200 | $354.39 | |
| SMA 50 | $368.02 | |
| EMA 200 | $349.89 | |
| EMA 50 | $365.38 | |
| MACD | $3.37 | |
| Beta | 0.82 | |
| ATR | $12.55 | |
| 14-Day RSI | 53.37 | |
| 10-Day Volatility | 35.91% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.17B | |
| EPS | $10.76 | |
| Gross Profit | $1.83B | |
| Gross Margin | 57.77% | |
| Operating Income | $893.22M | |
| Operating Margin | 28.22% | |
| Net Income | $642.63M | |
| Net Margin | 20.30% | |
| EBITDA | $1.10B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.55 | |
| 1.73 | ||
| 1.14 | ||
| - | ||
| 3 | ||
| 13.13 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 48.03 | |
| 9.83 | ||
| 2.42 | ||
| 38.48 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $2.56B | |
| $587.83M | ||
| $5.08B | ||
| $1.99B | ||
| $2.52B | ||
| $1.24B | ||
| Total Debt | $1.41B | |
| $491.09M | ||
| $103.78M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $2.52B | ||
| $935.45M | ||
| $1.34B | ||
| $0.00 | ||
| $206.24M | ||
| $0.00 | ||
| $112.25M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $652.56M | ||
| -$152.25M | ||
| -$237.21M | ||
| Capex | $112.75M | |
| $539.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Goldman Sachs | → | |
| RBC Capital | ||
| Morgan Stanley | → | |
| Guggenheim | → | |
| Evercore ISI Group | → | |
| Piper Sandler | ||
| HSBC | → | |
| B of A Securities | → | |
| Wells Fargo | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with WAT
FAQ
- What is the ticker symbol for Waters Corporation?
- The ticker symbol for Waters Corporation is NYSE:WAT
- Does Waters Corporation pay dividends?
- No, Waters Corporation does not pay dividends
- What sector is Waters Corporation in?
- Waters Corporation is in the Healthcare sector
- What industry is Waters Corporation in?
- Waters Corporation is in the Diagnostics & Research industry
- What country is Waters Corporation based in?
- Waters Corporation is headquartered in United States
- When did Waters Corporation go public?
- Waters Corporation initial public offering (IPO) was on November 17, 1995
- Is Waters Corporation in the S&P 500?
- Yes, Waters Corporation is included in the S&P 500 index
- Is Waters Corporation in the NASDAQ 100?
- No, Waters Corporation is not included in the NASDAQ 100 index
- Is Waters Corporation in the Dow Jones?
- No, Waters Corporation is not included in the Dow Jones index
- When was Waters Corporation last earnings report?
- Waters Corporation's most recent earnings report was on May 5, 2026
- When does Waters Corporation report earnings?
- The next expected earnings date for Waters Corporation is August 4, 2026
Data Sources & References
- WAT Official Website www.waters.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000697/000119312526041897/0001193125-26-041897-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- WAT Profile on Yahoo Finance finance.yahoo.com/quote/WAT
- WAT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wat
